The largest database of trusted experimental protocols

MRNA Precursor

mRNA precursor, also known as pre-mRNA, refers to the initial RNA transcript produced during gene expression before undergoing processing and maturation into the final, functional mRNA molecule.
This immature RNA form contains both coding sequences (exons) and non-coding sequences (introns) that must be precisely edited and spliced to generate the mature mRNA.
The mRNA precursor is a crucial intermediate step in the central dogma of molecular biology, transforming the genetic information stored in DNA into the templates used for protein synthesis.
Understanidng the complex mechanisms governing mRNA precursor maturation is essential for optimizing gene expression and advancing fields such as biotechnology, genetics, and molecular medicine.

Most cited protocols related to «MRNA Precursor»

TarBase5.0 contains data extracted from a total of 203 scientific papers resulting in 1333 entries describing a regulatory interaction between a miRNA and a target 3′ UTR (summarized in Table 1).

A list of all TarBase5.0 entries

OrganismNumber of papersNumber of entriesMicroarray datapSILAC data
Homo sapiens110285328474
Mus musculus2810513
D. melanogaster2377
C. elegans1814
Plants2130
Danio rerio11
Rat22
Total203514341474
The TarBase5.0 data set contains miRNA targets that tested either positive (induces target gene repression) or negative (no influence on target gene expression). For each experiment with a positive outcome the target site is described by the miRNA that binds it, the gene in which it occurs, the nature of the experiments that were conducted to test it, the sufficiency of the site to induce translational repression and/or cleavage, and the paper from which all these data is extracted. Additionally, for each miRNA and protein-coding gene, the database contains links to several other relevant and useful databases such as Ensembl (10 (link)), Hugo (11 (link)), UCSC genome browser (12 (link)) and SwissProt (13 (link)).
There are a number of direct and indirect experimental procedures that have been developed to test a possible miRNA–mRNA interaction. The entries in Tarbase5.0 are classified into four categories: TRUE or FALSE in the cases where an assay provides direct experimental evidence, or MICROARRAY and/or pSILAC in the cases that present only indirect evidence from high-throughput techniques to measure miRNA-mediated global transcriptomic or proteomic changes. All of these approaches make use of technology for miRNA knock down or overexpression. To overexpress a miRNA, expression constructs can be engineered using the mature miRNA, the precursor (hairpin) miRNA, or the pri-miRNA sequence for transfection into in vitro or in vivo transformed cells. Also, silencing of a specific miRNA can be accomplished by introducing chemically modified oligonucleotides that are perfectly complimentary to the mature miRNA (antagomirs) (14 (link)). These methods for modifying miRNA expression allow for several types of follow-up techniques to quantify and interpret differences in target gene expression. Below we provide a more detailed description of each of the four categories:
TRUE or FALSE: The most commonly used method for providing direct experimental evidence is the reporter gene assay. In its simplest form, an expression vector containing a reporter gene [i.e. Luciferase or Green Fluorescent Protein (GFP)] is first modified by cloning the predicted target 3′UTR downstream of the reporter gene, and then transfected into a cell line of interest in the absence and presence of the cognate miRNA. Despite the general utility of this approach to assay for 3′UTR-mediated effects on reporter protein expression, it is not informative for the precise location of the miRNA response element (MRE) or number of miRNA target sites in the 3′UTR. Integration of the reporter gene assay with site directed mutagenesis of the predicted MRE (and, further, restoring the complementarity of the miRNA–MRE interaction by mutating the mature miRNA sequence) yields a much more specific and direct result. To measure effects on reporter mRNA levels, the most commonly applied technique is quantitative RT-PCR (qRT-PCR). Measuring effects on both protein and mRNA levels can help provide information about the mode of miRNA-mediated silencing: mRNA translational repression or immediate RISC-mediated mRNA cleavage and degradation. A miRNA–MRE interaction is reported as TRUE or FALSE based on the results of the reporter gene assay.
MICROARRAY and/or pSILAC: These high-throughput approaches measure global changes in the transcriptome (15 (link)) or proteome (8 (link),16 (link)) given the presence or absence of a miRNA. Despite their power for large-scale analysis, these techniques only provide indirect evidence about a miRNA's targets since it is not possible to distinguish between primary direct targets and secondary indirect targets. Other high-throughput methods like degradome sequencing (17 (link),18 (link)) are also immensely useful but only in the scenarios where a miRNA induces RISC-mediated mRNA cleavage.
In order to facilitate user interaction, the query function is divided into several functionally related subgroups. The initial screen of the TarBase5.0 user interface allows users to query based on miRNA, gene and organism. For more advanced queries, the user can utilize the extended query options. In this case, the search menus are arranged into four functionally related groups.
The first group contains the fields with information about the miRNA–target interaction: the validity of the interaction (field ‘Support Type’, either true or false), the function of the interaction which can be either translational repression or mRNA cleavage (field ‘DataType’), the sufficiency of a single target site to exert the specific function (field ‘S_S_S’) and the number of miRNA response elements present in the specific UTR (field ‘MRE’).
The second group contains the fields that refer to the experimental methods that led to the reported result. The field ‘Direct Support’ refers to experimental procedures that provide direct evidence regarding the miRNA–target interaction (i.e. reporter gene assays) while ‘Indirect Support’ refers to experimental procedures that provide more global, system-wide miRNA-mediated effects (i.e. microarrays).
The third group corresponds to biological properties of the miRNA or target gene: biological functions (field ‘Protein Type’), specific expression profiles (field ‘miRNA Expression’) or the physiological processes in which this interaction is involved (field ‘Event or Pathology’). The fourth and final group contains some general query features such as the scientific paper (searchable by Author or PMID).
The results are presented in a similar format as the query fields. By default, the results screen (Figure 2) shows only the repression type, the miRNA identifier, the target gene identified by the HGNC symbol (if it is a human gene), the common gene name, the Refseq isoform id (particularly relevant in cases of gene variants or SNP haplotypes), the affected biological processes and the paper containing the information presented. Users can opt to view more detailed information by clicking on the ‘+’ box so that the expanded results view is opened (Figure 2). The additional information is divided into three categories: miRNA information, gene information and experimental conditions.

Example of a result screen for a TarBase query. The context-specific links to other resources are indicated by the blue arrows.

The ‘miRNA information’ category contains the properties of the specific miRNA such as the miRNA's sequence [extracted from miRBase (19 (link))], the number and sequences of the MREs, their locations within the gene's 3′UTR, and the affected tissues (extracted from the paper). The ‘Gene information’ category gathers mostly biological properties of the target gene like the protein type, Ensembl and SwissProt IDs and chromosome location, providing direct links to Ensembl, SwissProt and the UCSC browser respectively. Moreover, expression profiles and tumor involvement are also provided for human genes (information extracted from the Ensembl eGenetics database). Finally, the ‘Experimental conditions’ category provides the nature of the direct or indirect evidence for the miRNA–target gene interaction. The cell lines used to carry out the specific experiment are also presented in order to render the experimental conditions more complete and reproducible.
Publication 2008
We analyzed a dataset of oligodendrocyte differentiation from murine pons extracted from a recently published cellular atlas20 . We restricted the analysis to the trajectory of differentiation from oligodendrocyte precursor cells (OPCs) to mature oligodendrocytes by selecting cells that were labeled in the atlas as OPCs, COPs. NFOLs or MFOLs, for a total of 6307 cells.
As an initial step, for the Supp. Figure 7d-f, we performed a straightforward feature selection, first removing genes expressed lower than 15 spliced molecules, or lower than 8 unspliced molecules, requiring a minimal average spliced expression of 0.075 and minimal unspliced expression of 0.03 in the highest expressing cluster. A CV-mean fit was used to select the 606 most variable genes.
As the simple procedure above retained significant sex-driven batch effect (shown in Supp. Figure 7e), we then used a different approach aimed at minimizing batch effects by focusing on the genes that were uniquely relevant to the observed oligeodendrocytes. Specifically, a list of genes enriched in the oligodendrocyte lineage when compared to all other cell types was used to analyze the dataset. For each cell cluster we used the top 190 genes as sorted by enrichment (differential upregulation) scores, calculated as described in 20 . The resulting set of genes was subjected to further filtering where lowly detected genes where excluded, requiring at least 5 spliced and 3 unspliced mRNA molecules detected in the whole dataset, resulting in 606 genes. We then normalized the cell total molecule counts using the initial molecule count as normalization factor. For cell k-NN pooling we built a k-nearest neighbor graph (k=90) based on Euclidean distance in the top nine principal components. Data was clustered using Louvain community detection algorithm on the nearest neighbor graph and colored according a pseudotime computed by a principal curve. Finally, we calculated gammas, velocity and extrapolation as described above; transition probabilities were computed using n_sight=300 and log transform.
Publication 2018
Cells creatinol phosphate Gamma Rays Genes Genes, vif Mus Oligodendrocyte Precursor Cells Oligodendroglia Pons RNA, Messenger Transcriptional Activation Vision
piPipes comprises five pipelines designed to analyze small RNA-seq, RNA-seq, degradome- and CAGE-seq, ChIP-seq or genome-seq data. The small RNA-seq pipeline reports the abundance, length distribution, nucleotide composition and 5′-to-5′ distance (‘Ping-Pong’ signature) of piRNAs assigned to genomic annotations, including individual transposon families and piRNA clusters, the initial sources of piRNA precursor transcripts. The RNA-seq pipeline reports the normalized abundance of transcripts from both genes and transposons. The degradome-seq pipeline offers methods to identify piRNA-directed cleavage products. This pipeline can also be used to analyze any long RNA sequencing method designed to define RNA 5′ ends, e.g. CAGE-seq. The ChIP-seq pipeline uses the widely used peak-calling algorithm MACS2 (Zhang et al., 2008 (link)), focusing on piRNA clusters and transposons. The genome-seq pipeline detects novel transposition events as well as structural variation. Supplementary Figure S1 illustrates the general piPipes workflow, using the small RNA-seq pipeline as an example. First, all reads aligned to ribosomal RNA (rRNA) sequences are removed. The remaining reads are then mapped to microRNA (miRNA) hairpin sequences to quantify the abundance and 5′- and 3′-end heterogeneity of mature miRNAs. Reads that do not match rRNAs or miRNAs are then mapped to the reference genome. piPipes next assigns reads to different genomic features (e.g., transposons, piRNA clusters and genes) by their coordinates. To achieve maximal speed, piPipes parallelizes this step on multiple threads using ParaFly software from the Trinity package (Grabherr et al., 2011 (link)). For the reads assigned to each genomic feature, piPipes draws publication-quality graphs of length distribution and nucleotide composition, as well as the distance between the 5′ ends of two small RNAs from opposite strands of the same locus, a standard method for detecting piRNA ‘Ping-Pong’ amplification or siRNA phasing (Fig. 1A and Supplementary Fig. S1B). Furthermore, piPipes generates a table that summarizes the number of unique and multiple mappers counted as species (distinct sequences) or reads. The RNA-seq pipeline also starts with rRNA removal. The remaining reads are then mapped to the genome using STAR (Dobin et al., 2013 (link)). piPipes quantifies transcript abundance from genomic alignment by both Cufflinks (Trapnell et al., 2010 (link)) and HTSeq-count (Anders et al., 2014 (link)). In addition, direct mapping of the reads to the transcriptome is performed using Bowtie2 followed by eXpress quantification (Roberts and Pachter, 2013 (link)). Degradome-seq and CAGE-seq share the same pipeline because both methods aim to characterize the 5′ ends of RNAs. This pipeline discards reads that can only be mapped to the genome via soft clipping of their 5′ ends (i.e. the prefixes of these reads do not map to the genome). The alignment procedure is otherwise similar to that used for RNA-seq data. The nucleotide composition for each genomic feature is calculated as in the small RNA pipeline (Supplementary Fig. S3B). The ChIP-seq pipeline aligns the ChIP and input libraries to the genome using Bowtie2. piPipes calls peaks using MACS2 (Zhang et al., 2008 (link)), which supports both narrow (such as transcription factors) and broad (such as histone 3 trimethyl lysine 9, H3K9me3) peaks. Transcription start site, transcription end site and metagene analyses of different genomic features are implemented by bwtool (Pohl and Beato, 2014 (link)). The genome-seq pipeline applies different algorithms, including BreakDancer (Chen et al., 2009 (link)), RetroSeq (Hormozdiari et al., 2010 (link); Keane et al., 2013 (link)) and TEMP (Zhuang et al., 2014 (link)), to discover transposon insertion, deletion and other structural variation events (Supplementary Fig. S5). piPipes uses a Circos plot (Zhang et al., 2013 (link)) to represent the variant loci discovered by each algorithm across different chromosomes (Fig. 1D).

Gallery of piPipes Figures (A) Barplot representing length distribution of Drosophila w1 ovary small RNAs assigned to sense (blue) and antisense (red) strands of transposons. (B) Scatterplot comparing w1 to aubHN2/QC42 Drosophila ovary RNA-seq reads assigned to mRNA (NM; red), non-coding RNA (NR; green) and transposons (blue). (C) Metagene plot of H3K9me3 ChIP-seq of piRNA clusters from flies in which piwi mRNA was depleted by double-stranded RNA-triggered RNA driven by a triple Gal4 driver (SRX215630). (D) Circos plot representing the locations of, from the periphery to the center, cytological position, piRNA clusters, SV discovered by TEMP (tiles), retroSeq (tiles) and VariationHunter (links) using genomic sequencing of 2–4-day-old ovaries

The small RNA-seq, RNA-seq and ChIP-seq pipelines can each be run in two modes, allowing analysis of a single sample or a pair of samples. The dual-sample mode uses the output from the single-sample mode and performs pair-wise comparison as illustrated by balloonplots and scatterplots (Supplementary Fig. S1C and D). The comparison can be performed on miRNA, piRNA or mRNA. Figure 1B illustrates a scatterplot showing the mRNA abundance in an RNA-seq dataset analyzed by the RNA-seq pipeline in the dual-sample mode. The dual-sample mode of the RNA-seq pipeline also uses Cuffdiff (Trapnell et al., 2013 (link)) to perform differential analysis on genic transcripts. In the dual-sample mode, the ChIP-seq pipeline uses MACS2 to identify differentially enriched loci (Supplementary Fig. S4).
Publication 2014

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2020
The machine used for the pre-analysis was a HP Workstation xw9300 with a Dual Core AMD Opteron(tm) processor 275 2194.15 MHz and 8 Gb of RAM memory. We have used the stand-alone version for the adapter recognition step allowing only three mismatches and no gaps. The minimal size of the adapter recognized was set up to 10 nucleotides. The time process was 30 min for 6 millions reads. After that, sequences were annotated using human pre-miRNA and mature miRNA databases provided by the miRBase (http://microrna.sanger.ac.uk/sequences/) available at the SeqBuster server (15 min required). In addition, using the stand-alone version, the data were also mapped onto mRNA and genome databases (1 and 2.5 h required, respectively) (http://hgdownload.cse.ucsc.edu/goldenPath/hg18/bigZips/). The annotated files were uploaded to the server and stored for subsequent analyses.
For precursor-miRNAs annotation, the following parameters were configured: one mismatch, three nucleotides in the 3′ addition variants and the priority degree equal to 3. For miRNAs and miRNA*annotation, the following parameters were configured: one mismatch, three nucleotides in the 3′ or 5′ trimming variants, three nucleotides in the 3′ addition variants, a priority degree equal to 1 and 2 for the miRNA and the miRNA* databases, respectively, and the parental database was the precursor miRNA database. These options permitted the annotations of the following alignments: (i) perfect match, where the sequence is completely identical to the reference sequence; (ii) trimming at the 3′-end of the reference miRNA sequence, which is a miRNA variant several nucleotides shorter or longer that matches to the mature or precursor reference sequence, respectively; (iii) trimming at the 5′-end of the sequence, an analogous case focused in the 5′-end of the miRNA; (iv) nucleotide additions at the 3′-end of the sequence and (v) nucleotide substitutions, showing nucleotide modifications with respect to the reference sequence. The parameters for the alignment in mRNA and genome databases allowed as much as one mismatch and up to three nucleotide additions in the 3′-terminus. The priority parameter was equal to 4 and 5 for the mRNA and genome databases, respectively.
Publication 2009
Base Sequence Genome Homo sapiens Memory MicroRNAs Nucleotides Parent pre-miRNA RNA, Messenger

Most recents protocols related to «MRNA Precursor»

To show the mRNA level of app family members, RNA was extracted from whole larvae at 24hpf. Embryos of AB or appb +/+ background were used as controls. Each experiment was performed at least three times with four to five technical replicates (considered as "N") of 10 larvae each. Total RNA was extracted from 10 larvae, using TRI Reagent ® (Sigma Aldrich).
Then, RNA samples were treated with RQ1 1x RNase-free DNase reaction buffer and RQ1 RNase-free DNase (Promega kit). cDNA was synthesized using High-Capacity RNA-to-cDNA Kit (Applied Biosystems) and converted in a single-cycle reaction on a 2720 Thermal Cycler (Applied Biosystems). Quantitative PCR (qPCR) was performed with inventoried TaqMan Gene Expression Assays with FAM reporter dye (Thermo Fisher Scientific) in TaqMan Fast Advanced Master Mix (Applied Biosystems). The assay was carried out on Micro-Amp 96-well optical microtiter plates on a QuantStudio 3 Real-Time PCR System Software (Applied Biosystems). qPCR results were analysed with the QuantStudio Design and Analysis software v1.5.2 (Applied Biosystems). Briefly, CT from each sample was normalized with average CT:s of eef1a1l1 and actb1, then the relative quantity was determined using the ΔΔCT method (Livak & Schmittgen, 2001) (link) with a sample of wildtype embryos (6-72 hpf and adult brain) as the calibrator. TaqMan Gene Expression Assays (Applied Biosystems) were used for the following genes: Amyloid Beta (A4) Precursor Protein A (appa, Dr 03144364_m1 and Dr 03144365_m1), Amyloid Beta (A4) Precursor Protein B (appb, Dr 03080308_m1 and Dr 03080304_m1 ), Amyloid Beta Precursor Like Protein 1 (aplp1, AJCSWD2), Amyloid Beta Precursor Like Protein 2 (aplp2, Dr 03437773_m1), Eukaryotic Translation Elongation Factor 1 Alpha 1, Like 1 (eef1a1l1, Dr 03432748_m1) and Actin Beta 1 (actb1, Dr 03432610_m1). To confirm the deletion of appb in appb P-/-SYBR green primers were designed to amplify exon 16-17 in appb and eef1a1 primer pairs used as housekeeping gene (Extended Dats Table 4-3).
e N e u r o A c c e p t e d M a n u s c r i p t
Publication 2024
The level of the 9S rRNA precursor of the p5S transcript was determined by qPCR as described above for the polar and non-polar mRNAs with two exceptions. First, cells were grown to the mid-exponential phase and then transferred to either permissive (30 °C) or restrictive (42 °C or 43 °C) temperature for 1 h of additional growth. Second, expression was normalized using gyrA mRNA as a reference.
Full text: Click here
Publication 2024

Example 4

Preproendothelin-1 (ppET-1) is the precursor polypeptide processed to big ET-1 and then cleaved by ECE-1 to produce the active ET-1 peptide. Peripheral blood derived macrophage were cultured with media only (control), 100 ng/ml LPS, 10 ng/ml HIV Nef or 10 ng/ml HIV gp120 for 4 hours. PpET-1 mRNA was detected using real time quantitative PCR and normalized against 18s rRNA. All other significant differences are denoted by the brackets. As shown in FIG. 3, all HIV positive patients had significantly higher expression of ppET-1 mRNA when compared to the healthy controls under all treatment conditions (P<0.003). ppET-1 mRNA expression was highest in macrophages from HIVAN patients treated with HIV Nef when compared to all other groups (P<0.003). African American HIV positive patients, including HIVAN patients, had significantly higher amounts of ppET-1 mRNA expressed in cells cultured in media or treated with HIV Nef compared to HIV+ Caucasian patients (P<0.003). LPS treatment of HIVAN patients' macrophages stimulated significantly more ppET-1 (P<0.03) than LPS treatment of macrophages from Caucasian HIV positive patients. In all cases, except cells from the healthy controls, LPS increased ppET-1 mRNA expression when compared to cells cultured in media only (P<0.02).

Full text: Click here
Patent 2024
African American BLOOD Caucasoid Races Cells Culture Media HIV Envelope Protein gp120 HIV Seropositivity Macrophage Patients Peptides Polypeptides PPET Preproendothelin-1 Real-Time Polymerase Chain Reaction RNA, Messenger RNA, Ribosomal, 18S

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2024
GLA gene knockout (KO) mice were used as Fabry disease model animals. These mice were generated in the Shanghai Model Organisms Center (Shanghai, China) using CRISPR/Cas9 technology. Genotyping was performed using DNA from collected tail samples to confirm the loss of the whole precursor-Gal gene encoding sequence (1400 bp). All mice used in the study were housed and bred in the Shanghai Model Organisms Center (Shanghai, China). During all experiments, mice had free access to clean food and water in a facility with a 12-h light/dark cycle. Animal experiments were authorized by the Animal Care and Use Committee of Shanghai Nanfang Model Biotechnology Co., Ltd (Shanghai, China) (2021-0012). Mice were randomly divided into three groups: a control group (PBS), a low-dose mRNA group (1 mg/kg), and a high-dose mRNA group (3 mg/kg). The mRNA encapsulated by LNP was injected into the mouse body via tail vein injection. The plasma, heart, liver, and kidneys of mice were collected at different times for testing α-Gal A activity and Lyso-Gb3 levels.
Male mice (wild-type) were housed in the Shanghai Model Organisms Center (Shanghai, China). The firefly luciferase mRNA (NCBI accession number M15077.1) encapsulated in LNP (1 mg/kg) was injected into the mouse body via tail vein injection. Fluorescence was observed at different locations and time points (0, 2, 6, 12, 24, 48, and 72 h) using a small animal imager (Clinx, IVScope 8000, Shanghai, China).
Full text: Click here
Publication 2024

Top products related to «MRNA Precursor»

Sourced in United States, China, Japan, Germany, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Netherlands, Belgium, Lithuania, Denmark, Singapore, New Zealand, India, Brazil, Argentina, Sweden, Norway, Austria, Poland, Finland, Israel, Hong Kong, Cameroon, Sao Tome and Principe, Macao, Taiwan, Province of China, Thailand
TRIzol reagent is a monophasic solution of phenol, guanidine isothiocyanate, and other proprietary components designed for the isolation of total RNA, DNA, and proteins from a variety of biological samples. The reagent maintains the integrity of the RNA while disrupting cells and dissolving cell components.
Sourced in United States, United Kingdom, China
The SMART-RACE kit is a tool for rapid amplification of cDNA ends, enabling efficient 5' and 3' cDNA amplification from limited RNA samples. The kit provides a simple and reliable method for generating full-length cDNA sequences.
Sourced in United States, United Kingdom, Japan
The pGEM-T Vector System is a convenient system for the cloning of PCR products. The vector is prepared by cutting with the restriction enzyme EcoRV and adding a 3' terminal thymidine to both ends. This allows for the direct insertion of PCR products generated by DNA polymerases that add a single 3' adenosine overhang. The vector contains the lacZ gene, which allows for blue/white color screening of recombinant clones.
Sourced in United States, China, Germany, United Kingdom, Canada, Japan, France, Italy, Switzerland, Australia, Spain, Belgium, Denmark, Singapore, India, Netherlands, Sweden, New Zealand, Portugal, Poland, Israel, Lithuania, Hong Kong, Argentina, Ireland, Austria, Czechia, Cameroon, Taiwan, Province of China, Morocco
Lipofectamine 2000 is a cationic lipid-based transfection reagent designed for efficient and reliable delivery of nucleic acids, such as plasmid DNA and small interfering RNA (siRNA), into a wide range of eukaryotic cell types. It facilitates the formation of complexes between the nucleic acid and the lipid components, which can then be introduced into cells to enable gene expression or gene silencing studies.
Sourced in United States, Germany, China, Japan, United Kingdom, Canada, France, Italy, Australia, Spain, Switzerland, Belgium, Denmark, Netherlands, India, Ireland, Lithuania, Singapore, Sweden, Norway, Austria, Brazil, Argentina, Hungary, Sao Tome and Principe, New Zealand, Hong Kong, Cameroon, Philippines
TRIzol is a monophasic solution of phenol and guanidine isothiocyanate that is used for the isolation of total RNA from various biological samples. It is a reagent designed to facilitate the disruption of cells and the subsequent isolation of RNA.
Sourced in Germany, United States, China, Japan, United Kingdom, Netherlands, France, Canada, Italy, Spain, Denmark, Belgium
The MiScript II RT Kit is a laboratory equipment product designed for reverse transcription of microRNA (miRNA) and other small RNA molecules. The kit provides the necessary components for the conversion of RNA into complementary DNA (cDNA), which can be used for downstream applications such as real-time PCR analysis.
Sourced in United States, Germany, United Kingdom, Japan, Lithuania, France, Italy, China, Spain, Canada, Switzerland, Poland, Australia, Belgium, Denmark, Sweden, Hungary, Austria, Ireland, Netherlands, Brazil, Macao, Israel, Singapore, Egypt, Morocco, Palestine, State of, Slovakia
The High-Capacity cDNA Reverse Transcription Kit is a laboratory tool used to convert RNA into complementary DNA (cDNA) molecules. It provides a reliable and efficient method for performing reverse transcription, a fundamental step in various molecular biology applications.
Sourced in Germany, United States, China, Canada, Switzerland, United Kingdom, Spain, Netherlands, France, Japan, Italy
The MiScript SYBR Green PCR Kit is a laboratory product designed for real-time PCR analysis. It provides the necessary reagents to perform quantitative reverse transcription PCR (RT-qPCR) experiments, including the SYBR Green I dye for detection of amplified DNA.
Sourced in Germany, United States, United Kingdom, Spain, Netherlands, Canada, France, Japan, China, Italy, Switzerland, Australia, Sweden, India, Singapore, Denmark, Belgium
The RNeasy kit is a laboratory equipment product that is designed for the extraction and purification of ribonucleic acid (RNA) from various biological samples. It utilizes a silica-membrane-based technology to efficiently capture and isolate RNA molecules.
Sourced in Germany, United States, United Kingdom, Netherlands, Spain, Japan, Canada, France, China, Australia, Italy, Switzerland, Sweden, Belgium, Denmark, India, Jamaica, Singapore, Poland, Lithuania, Brazil, New Zealand, Austria, Hong Kong, Portugal, Romania, Cameroon, Norway
The RNeasy Mini Kit is a laboratory equipment designed for the purification of total RNA from a variety of sample types, including animal cells, tissues, and other biological materials. The kit utilizes a silica-based membrane technology to selectively bind and isolate RNA molecules, allowing for efficient extraction and recovery of high-quality RNA.

More about "MRNA Precursor"

mRNA Precursor, also known as pre-mRNA, is the initial RNA transcript produced during gene expression before undergoing processing and maturation into the final, functional mRNA molecule.
This immature RNA form contains both coding sequences (exons) and non-coding sequences (introns) that must be precisely edited and spliced to generate the mature mRNA.
The mRNA precursor is a crucial intermediate step in the central dogma of molecular biology, transforming the genetic information stored in DNA into the templates used for protein synthesis.
Understanding the complex mechanisms governing mRNA precursor maturation is essential for optimizing gene expression and advancing fields such as biotechnology, genetics, and molecular medicine.
Researchers often utilize various tools and techniques to study mRNA precursor, including TRIzol reagent for RNA extraction, SMART-RACE kit for rapid amplification of cDNA ends, PGEM-T vector system for cloning, and Lipofectamine 2000 for transfection.
Additionally, reverse transcription kits like the MiScript II RT Kit and High-Capacity cDNA Reverse Transcription Kit, as well as real-time PCR kits such as the MiScript SYBR Green PCR Kit, are commonly employed to analyze mRNA precursor expression and splicing.
The RNeasy kit and RNeasy Mini Kit are also widely used for purifying and concentrating RNA, including mRNA precursor, from various biological samples.
Optimizing these protocols and using the most reliable and effective methods is crucial for enhancing the reproducibility and accuracy of mRNA precursor research, as highlighted by the AI-driven platform PubCompare.ai.